| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Schwabe Stefan K.F. | Executive Vice President & CMO | Dec 21, 2020 | Sale | $17.54 | 92,694 | 1,626,047 | 49,119 | Dec 22, 2020, 05:49 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Schwabe Stefan K.F. | Executive Vice President & CMO | Dec 14, 2020 | Sale | $15.63 | 107,306 | 1,677,180 | 56,425 | Dec 15, 2020, 08:20 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | Schwabe Stefan K.F. | Executive VP R&D, CMO | Jun 18, 2018 | Sale | $31.59 | 120,000 | 3,790,952 | 61,967 | Jun 19, 2018, 05:51 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | Schwabe Stefan K.F. | Executive Vice President R&D | Sep 07, 2017 | Option Exercise | $29.75 | 190,000 | 5,652,975 | 96,855 | Sep 11, 2017, 07:22 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | Schwabe Stefan K.F. | Executive Vice President R&D | Jul 28, 2015 | Sale | $21.20 | 2,350 | 49,827 | 1,700 | Jul 29, 2015, 06:26 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | Schwabe Stefan K.F. | Executive Vice President R&D | Jul 13, 2015 | Sale | $19.23 | 1,950 | 37,498 | 2,350 | Jul 29, 2015, 06:19 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | Schwabe Stefan K.F. | Executive Vice President R&D | Jul 13, 2015 | Sale | $19.23 | 1,950 | 37,498 | 844 | Jul 14, 2015, 09:21 AM | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | Schwabe Stefan K.F. | Executive Vice President R&D | Jun 12, 2015 | Sale | $18.27 | 2,051 | 37,472 | 2,794 | Jun 15, 2015, 04:29 PM | |
| SUPN | SUPERNUS PHARMACEUTICALS INC | Schwabe Stefan K.F. | Executive Vice President R&D | Jun 11, 2015 | Sale | $16.39 | 3,631 | 59,521 | 7,131 | Jun 12, 2015, 04:21 PM |
Menu